Kim Oelkers

The accessibility of data on environmental risk assessment of pharmaceuticals – are environmental risk assessments information on emissions with respect to international and European environmental information law?

Kim Oelkers · Regulatory Toxicology and Pharmacology · 2019 · 25 citations · Full text

Law, Environmental Law, Environmental Sciences +12

The accessibility of data on environmental risk assessment of pharmaceuticals: Is the marketing authorisation procedure in conflict with the international right of access to environmental information?

Kim Oelkers, Carolin Floeter · Environmental Sciences Europe · 2019 · 22 citations · Full text

Law, Environmental Law, Environmental Sciences +12

PharmCycle: a holistic approach to reduce the contamination of the aquatic environment with antibiotics by developing sustainable antibiotics, improving the environmental risk assessment of antibiotics, and reducing the discharges of antibiotics in the wastewater outlet

Jörg Andrä, Falk Beyer, Gesine Cornelissen et al. · Environmental Sciences Europe · 2018 · 13 citations · Full text

Natural Sciences, Environmental Sciences, Pharmaceutical Biotechnology +11

Is the objective of the Water Framework Directive to deal with pollutant emissions at source coherently implemented by the EU's substance-specific legal acts? A comparison of the environmental risk control of pharmaceutical legislation with the REACH-, Biocidal Products- and Plant Protection Products Regulation

Kim Oelkers · Sustainable Chemistry and Pharmacy · 2021 · 10 citations

Public Affairs, Environmental Law, Regulatory Policy +13